Skip to main content
. Author manuscript; available in PMC: 2017 Sep 1.
Published in final edited form as: J Psychosom Res. 2016 Jul 19;88:36–41. doi: 10.1016/j.jpsychores.2016.07.011

Table 2.

Correlations and mean estimates for hypothesized predictors of depression response after 16 weeks of depression treatment

1 Predictor 2 Mean ± SD / N
(%)
3 Estimate (95% CI) P

BDI-II score
 Baseline 30.2 ± 8.5 0.19 (0.03, 0.35) 0.02

Prior depressive episode
 Yes 122 (77.7%) 8.3 ± 7.7 (6.9, 9.7) 0.53
 No 35 (22.3%) 9.3 ± 8.1 (6.6, 12.0)

BAI score
 Baseline 14.5 ± 8.9 0.04 (−0.13, 0.22) 0.61

Stressful life events

Stressful life events score (SLEQ)
  Baseline (prior 12 months) 8.9 ± 7.0 0.02 (−0.15, 0.20) 0.81
  Treatment Weeks 1-8 4.3 ± 4.1 0.19 (0.02, 0.36) 0.03
  Treatment Weeks 9-16 3.7 ± 4.0 0.40 (0.24, 0.55) <0.0001

Medical events during treatment
 Hospitalization 0.40
   Yes 32 (20.4) 7.3 ± 9.0 (4.1, 10.4)
   No 125 (79.6) 8.9 ± 8.0 (7.4, 10.3)
 Emergency department visit 0.90
   Yes 31 (19.7) 8.7 ± 8.6 (5.7, 11.8)
   No 126 (80.3) 8.5 ± 8.2 (7.0, 9.9)

Depression Treatment Adherence

 Medication compliance (% of pills
 removed from container)
97.0 ± 5.5 −0.47 (−0.76, 0.05) 0.08

 % CBT homework completed 59.7± 26.8 −0.29 (−0.44, −0.12) 0.001
1

Depression scores at 16 weeks are regressed on the hypothesized predictor, controlling for age, baseline depression scores and baseline antidepressant use. Cardiac or other medical events occurring during treatment were also included in all models except SLEQ. BAI models were further adjusted for anxiolytic use at baseline.

2

Summary scores for the continuous predictor variables are reported as mean ± SD. Categorical variables are reported as the number and (%) of participants.

3

Estimates are presented as partial Fisher z-transformed Pearson correlations for continuous predictors and mean ± SD post treatment BDI-II scores for dichotomous predictors.